Aion Therapeutic Inc.
AION
CNSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 843.90K | 589.30K | 271.70K | 164.50K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 843.90K | 589.30K | 271.70K | 164.50K | -- |
| Cost of Revenue | 502.90K | 327.10K | 150.80K | 43.20K | -- |
| Gross Profit | 341.00K | 262.20K | 120.90K | 121.30K | -- |
| SG&A Expenses | 1.38M | 1.15M | 933.00K | 724.10K | 580.70K |
| Depreciation & Amortization | 72.90K | 52.00K | 31.10K | 11.20K | 4.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.96M | 1.53M | 1.11M | 778.40K | 585.20K |
| Operating Income | -1.12M | -941.20K | -843.20K | -614.00K | -585.20K |
| Income Before Tax | -4.96M | -4.66M | -4.64M | -813.90K | -694.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.96 | -4.66 | -4.64 | -0.81 | -0.69 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.96M | -4.66M | -4.64M | -813.90K | -694.00K |
| EBIT | -1.12M | -941.20K | -843.20K | -614.00K | -585.20K |
| EBITDA | -1.10M | -730.20K | -515.70K | -293.60K | -261.20K |
| EPS Basic | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 1.66B | 1.37B | 1.06B | 800.78M | 632.19M |
| Average Diluted Shares Outstanding | 1.66B | 1.37B | 1.06B | 800.78M | 632.19M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
